Hemostatic Disorder
17
1
2
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
2 terminated out of 17 trials
71.4%
-15.1% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
Quantra Point-of-Care Hemostasis Monitoring
Examining the Experiences of Children With Blood Disorders
Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study.
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
Influence of Cardiac Implantable Electronic Devices on the Hemostatic System
Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System
To Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During POEM Using GF 1500 UGI Scope
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Thrombin in Cardiac Surgery
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
Copeptin and Psychological Stress of Medic During COVID-19 Pandemic
Gyeongsang National University Hospital Registry
Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
Hemostatic Disorders on Intensive Care Patients.
Viscoelastic Tests-Guided Therapy In Liver Transplantation
A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China